[BIO-B] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[BIO-B] Bio-Rad Laboratories, Inc.
Announcement Date
31-Oct-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 130.16%
YoY- 514.71%
Quarter Report
BIO-B's Result
BIO-B's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 649,729 632,124 680,800 747,049 647,263 560,633 545,138 2.96%
PBT 861,620 137,102 -209,168 5,022,226 1,684,461 -335,216 350,131 16.17%
Tax 208,448 30,845 -44,936 1,094,193 369,637 -76,400 80,805 17.09%
NP 653,172 106,257 -164,232 3,928,033 1,314,824 -258,816 269,326 15.89%
Tax Rate -24.19% -22.50% - -21.79% -21.94% - -23.08% -
Total Cost -3,443 525,867 845,032 -3,180,984 -667,561 819,449 275,812 -
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 100.53 16.81 -24.12 525.81 203.14 -46.16 49.41 12.55%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 23.37 3.65 -5.53 131.75 44.24 -8.68 9.02 17.17%
EPS Diluted 23.34 3.64 -5.52 129.96 43.64 -8.68 8.89 17.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.